Literature DB >> 19960275

Distribution and expression pattern of claudins 6, 7, and 9 in diffuse- and intestinal-type gastric adenocarcinomas.

Erika Rendón-Huerta1, Fortoul Teresa, Gorráez María Teresa, Garcia-Samper Xochitl, Alvarez-Fernández Georgina, Zavala-Zendejas Veronica, Luis Felipe Montaño.   

Abstract

INTRODUCTION: Intestinal- and diffuse-type gastric adenocarcinomas differ in clinical outcome and genetic profile. Abnormal claudin expression has been well documented in several malignancies. Our aim was to find specific claudin markers for each type.
METHODS: Fifty paraffin-embedded tissue blocks of diffuse- and intestinal-type gastric adenocarcinomas and fresh gastric biopsies obtained endoscopically from 20 patients with a presumptive diagnosis of gastric cancer were analyzed. Claudin-specific polyclonal and monoclonal antibodies were used for immunohistochemistry and Western blot analysis in total lysate and subcellular fractions.
RESULTS: Claudin-6 expression was high in both types. Claudin-7 was expressed mainly in the diffuse-type whereas claudin-9 was mainly found in the apical membrane of the gland cells in the intestinal-type. Strong claudin-9 expression was associated with higher mortality rate (66%) in the diffuse type vs the intestinal type (25%) after a 2-year follow-up.
CONCLUSION: Claudins 6, 7, and 9 expressions are closely related to gastric carcinogenesis, and their detection is a useful prognostic marker in "intestinal-" and "diffuse-type" gastric adenocarcinomas.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19960275     DOI: 10.1007/s12029-009-9110-y

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  54 in total

Review 1.  Tight junction proteins.

Authors:  L González-Mariscal; A Betanzos; P Nava; B E Jaramillo
Journal:  Prog Biophys Mol Biol       Date:  2003-01       Impact factor: 3.667

2.  Chronic exposure of LLC-PK1 epithelia to the phorbol ester TPA produces polyp-like foci with leaky tight junctions and altered protein kinase C-alpha expression and localization.

Authors:  J M Mullin; A P Soler; K V Laughlin; J A Kampherstein; L M Russo; D T Saladik; K George; R D Shurina; T G O'Brien
Journal:  Exp Cell Res       Date:  1996-08-25       Impact factor: 3.905

3.  Retinoid X receptor alpha and retinoic acid receptor gamma mediate expression of genes encoding tight-junction proteins and barrier function in F9 cells during visceral endodermal differentiation.

Authors:  H Kubota; H Chiba; Y Takakuwa; M Osanai; H Tobioka; G Kohama; M Mori; N Sawada
Journal:  Exp Cell Res       Date:  2001-02-01       Impact factor: 3.905

Review 4.  Increased tight junction permeability can result from protein kinase C activation/translocation and act as a tumor promotional event in epithelial cancers.

Authors:  J M Mullin; K V Laughlin; N Ginanni; C W Marano; H M Clarke; A Peralta Soler
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

5.  Claudins 1, 3, 4 and 5 in gastric carcinoma, loss of claudin expression associates with the diffuse subtype.

Authors:  Y Soini; S Tommola; H Helin; P Martikainen
Journal:  Virchows Arch       Date:  2005-10-12       Impact factor: 4.064

6.  Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells.

Authors:  N Murata-Kamiya; Y Kurashima; Y Teishikata; Y Yamahashi; Y Saito; H Higashi; H Aburatani; T Akiyama; R M Peek; T Azuma; M Hatakeyama
Journal:  Oncogene       Date:  2007-01-22       Impact factor: 9.867

7.  Gastric and intestinal claudin expression at the invasive front of gastric carcinoma.

Authors:  Yoshiko Matsuda; Shuho Semba; Junya Ueda; Takeichi Fuku; Tadateru Hasuo; Hideki Chiba; Norimasa Sawada; Yoshikazu Kuroda; Hiroshi Yokozaki
Journal:  Cancer Sci       Date:  2007-04-24       Impact factor: 6.716

Review 8.  The epidemiology of gastric cancer.

Authors:  David M Roder
Journal:  Gastric Cancer       Date:  2002       Impact factor: 7.370

9.  Claudin-4, mitogen-activated protein kinase kinase 4, and stratifin are markers of gastric adenocarcinoma precursor lesions.

Authors:  Steven C Cunningham; Farin Kamangar; Min P Kim; Sommer Hammoud; Raqeeb Haque; Christine A Iacobuzio-Donahue; Anirban Maitra; Raheela Ashfaq; Steven Hustinx; Richard E Heitmiller; Michael A Choti; Keith D Lillemoe; John L Cameron; Charles J Yeo; Richard D Schulick; Elizabeth Montgomery
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-02       Impact factor: 4.254

10.  Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells.

Authors:  M Furuse; K Furuse; H Sasaki; S Tsukita
Journal:  J Cell Biol       Date:  2001-04-16       Impact factor: 10.539

View more
  19 in total

1.  Tight junction protein claudin-6 inhibits growth and induces the apoptosis of cervical carcinoma cells in vitro and in vivo.

Authors:  Xiaowei Zhang; Yang Ruan; Yanru Li; Dongjing Lin; Chengshi Quan
Journal:  Med Oncol       Date:  2015-03-31       Impact factor: 3.064

Review 2.  Gastric cancer research in Mexico: a public health priority.

Authors:  Clara Luz Sampieri; Mauricio Mora
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

3.  Claudin-6 increases SNAI1, NANOG and SOX2 gene expression in human gastric adenocarcinoma AGS cells.

Authors:  Priscila Anhel Medrano-Gonzálezl; Franklin Cruz-Villegas; Alejandro Alarcón Del Carmen; Luis Felipe Montaño; Erika Patricia Rendón-Huerta
Journal:  Mol Biol Rep       Date:  2022-09-28       Impact factor: 2.742

4.  Gastric cancer with enhanced apical junction pathway has increased metastatic potential and worse clinical outcomes.

Authors:  Hideo Takahashi; Masanori Oshi; Li Yan; Itaru Endo; Kazuaki Takabe
Journal:  Am J Cancer Res       Date:  2022-05-15       Impact factor: 5.942

5.  A spontaneous metastasis model reveals the significance of claudin-9 overexpression in lung cancer metastasis.

Authors:  Rajesh K Sharma; Zinal S Chheda; Biswa Pratim Das Purkayastha; Jorge G Gomez-Gutierrez; Venkatakrishna R Jala; Bodduluri Haribabu
Journal:  Clin Exp Metastasis       Date:  2015-12-15       Impact factor: 5.150

6.  Claudin-6 is a single prognostic marker and functions as a tumor-promoting gene in a subgroup of intestinal type gastric cancer.

Authors:  Tomohiro Kohmoto; Kiyoshi Masuda; Katsutoshi Shoda; Rizu Takahashi; Sae Ujiro; Shoichiro Tange; Daisuke Ichikawa; Eigo Otsuji; Issei Imoto
Journal:  Gastric Cancer       Date:  2019-10-25       Impact factor: 7.370

7.  The level of claudin-7 is reduced as an early event in colorectal carcinogenesis.

Authors:  Jette Bornholdt; Stine Friis; Sine Godiksen; Steen S Poulsen; Eric Santoni-Rugiu; Hanne C Bisgaard; Inger M B Lothe; Tone Ikdahl; Kjell M Tveit; Egil Johnson; Elin H Kure; Lotte K Vogel
Journal:  BMC Cancer       Date:  2011-02-10       Impact factor: 4.430

Review 8.  Emerging roles of claudins in human cancer.

Authors:  Mi Jeong Kwon
Journal:  Int J Mol Sci       Date:  2013-09-04       Impact factor: 5.923

Review 9.  Claudins overexpression in ovarian cancer: potential targets for Clostridium Perfringens Enterotoxin (CPE) based diagnosis and therapy.

Authors:  Diana P English; Alessandro D Santin
Journal:  Int J Mol Sci       Date:  2013-05-17       Impact factor: 5.923

10.  Claudin-6: a novel receptor for CPE-mediated cytotoxicity in ovarian cancer.

Authors:  M Lal-Nag; M Battis; A D Santin; P J Morin
Journal:  Oncogenesis       Date:  2012-11-12       Impact factor: 7.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.